160 related articles for article (PubMed ID: 30541518)
1. Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report.
Tanimoto A; Takeuchi S; Kotani H; Yamashita K; Yamada T; Ohtsubo K; Ebi H; Ikeda H; Yano S
BMC Pulm Med; 2018 Dec; 18(1):193. PubMed ID: 30541518
[TBL] [Abstract][Full Text] [Related]
2. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
Jeon SY; Lee NR; Yim CY
BMC Nephrol; 2019 Jan; 20(1):1. PubMed ID: 30606155
[TBL] [Abstract][Full Text] [Related]
3. A case of rapidly growing pulmonary carcinosarcoma.
Sato S; Koike T; Yamato Y; Yoshiya K; Motono N; Takeshige M; Homma K; Koizumi N; Yokoyama A; Tsukada H
Int J Clin Oncol; 2010 Jun; 15(3):319-24. PubMed ID: 20217450
[TBL] [Abstract][Full Text] [Related]
4. [First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer].
Maráz A; Bodrogi I; Csejtei A; Dank M; Géczi L; Küronya Z; Mangel L; Petrányi A; Szûcs M; Bodoky G
Magy Onkol; 2013 Sep; 57(3):173-6. PubMed ID: 24107823
[TBL] [Abstract][Full Text] [Related]
5. The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Nakamura T; Matsumine A; Kawai A; Araki N; Goto T; Yonemoto T; Sugiura H; Nishida Y; Hiraga H; Honoki K; Yasuda T; Boku S; Sudo A; Ueda T
Cancer; 2016 May; 122(9):1408-16. PubMed ID: 26970174
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction between pazopanib and cisplatin regimen.
Imbs DC; Diéras V; Bachelot T; Campone M; Isambert N; Joly F; Jimenez M; Lafont T; Chatelut E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):385-92. PubMed ID: 26779916
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Lung Carcinosarcoma and Other Rare Histologic Subtypes of Non-small Cell Lung Cancer.
Yang H; Lin Y; Liang Y
Curr Treat Options Oncol; 2017 Aug; 18(9):54. PubMed ID: 28795312
[TBL] [Abstract][Full Text] [Related]
8. Carcinosarcoma of the lung mis-diagnosed preoperatively as a mediastinal tumor.
Chen F; Tatsumi A
Jpn J Thorac Cardiovasc Surg; 1999 Dec; 47(12):629-32. PubMed ID: 10658383
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy.
Gerullis H; Eimer C; Ecke TH; Georgas E; Arndt C; Otto T
Anticancer Drugs; 2013 Apr; 24(4):422-5. PubMed ID: 23407060
[TBL] [Abstract][Full Text] [Related]
10. An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma.
Sternberg CN; Davis ID; Deen KC; Sigal E; Hawkins RE
Oncology; 2014; 87(6):342-50. PubMed ID: 25227656
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases.
Yang SY; Kim DG; Lee SH; Chung HT; Paek SH; Hyun Kim J; Jung HW; Han DH
Cancer; 2008 Apr; 112(8):1780-6. PubMed ID: 18300239
[TBL] [Abstract][Full Text] [Related]
12. Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial.
Necchi A; Mariani L; Zaffaroni N; Schwartz LH; Giannatempo P; Crippa F; Morosi C; Lanocita R; Sava T; Ortega C; Messina C; Sacco C; Pennati M; Daidone MG; Nicolai N; De Braud F; Gianni AM; Salvioni R
Lancet Oncol; 2012 Aug; 13(8):810-6. PubMed ID: 22819172
[TBL] [Abstract][Full Text] [Related]
13. Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Grassi P; Verzoni E; Ratta R; Porcu L; Prisciandaro M; Mennitto A; Calareso G; de Braud F; Procopio G
Drugs R D; 2017 Sep; 17(3):461-467. PubMed ID: 28801802
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
Aiba H; Kimura H; Yamada S; Okamoto H; Hayashi K; Miwa S; Kawaguchi Y; Saito S; Sakai T; Tatematsu T; Nakanishi R; Murakami H
PLoS One; 2021; 16(7):e0254866. PubMed ID: 34270626
[TBL] [Abstract][Full Text] [Related]
15. Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial.
Mir O; Cropet C; Toulmonde M; Cesne AL; Molimard M; Bompas E; Cassier P; Ray-Coquard I; Rios M; Adenis A; Italiano A; Bouché O; Chauzit E; Duffaud F; Bertucci F; Isambert N; Gautier J; Blay JY; Pérol D;
Lancet Oncol; 2016 May; 17(5):632-41. PubMed ID: 27068858
[TBL] [Abstract][Full Text] [Related]
16. Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.
Nishikawa T; Hasegawa K; Yabuno A; Yoshida H; Yasuda M; Kozawa E; Fujiwara K
J Gynecol Oncol; 2017 Jan; 28(1):e25. PubMed ID: 27958685
[No Abstract] [Full Text] [Related]
17. Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.
Chow W; Frankel P; Ruel C; Araujo DM; Milhem M; Okuno S; Hartner L; Undevia S; Staddon A
Cancer; 2020 Jan; 126(1):105-111. PubMed ID: 31509242
[TBL] [Abstract][Full Text] [Related]
18. Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer.
Altorki N; Lane ME; Bauer T; Lee PC; Guarino MJ; Pass H; Felip E; Peylan-Ramu N; Gurpide A; Grannis FW; Mitchell JD; Tachdjian S; Swann RS; Huff A; Roychowdhury DF; Reeves A; Ottesen LH; Yankelevitz DF
J Clin Oncol; 2010 Jul; 28(19):3131-7. PubMed ID: 20516450
[TBL] [Abstract][Full Text] [Related]
19. Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review.
Hayashi H; Makiyama A; Okumura N; Yasufuku I; Saigo C; Takeuchi T; Miyazaki T; Tanaka Y; Matsuhashi N; Murase K; Takahashi T; Futamura M; Yoshida K
BMC Gastroenterol; 2022 Jul; 22(1):360. PubMed ID: 35902814
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report.
Puliafito I; Russo A; Sciacca D; Puglisi C; Giuffrida D
J Med Case Rep; 2020 Jan; 14(1):7. PubMed ID: 31924259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
